The Securities and Exchanges Board of India's directive to BSE Ltd on regulatory fees will cost the stock exchange Rs 96 crore for the FY07-23 period.Brokerage HDFC Securities, however, said the exchange can reduce the impact of higher regulatory fees by increasing transaction charges by around 25 percent and reducing clearing charges by 10 percent. These changes can reduce the impact of the SEBI'...

Biocon Biologics inks pact with Sandoz for sale of 2 biosimilar products in AustraliaThe agreement provides Sandoz the exclusive rights to promote, sell and distribute biosimilars Trastuzumab and Bevacizumab in Australia, Biocon Biologics said in a statement.Biocon Biologics on Friday said it has inked a five-year pact with pharmaceutical company Sandoz AG regarding the sale and distribution of tw...

The government hiked the securities transactions tax, or STT, on the sale of futures and options in the Finance Bill passed in the Lok Sabha on Friday.For sale of futures in securities, the STT rate has been increased from 0.01% to 0.0125%, which translates to an increase of 25%. This means that for a trade value of Rs 1 crore, an STT of Rs 1,250 will be payable from April 1 this year as against R...

Ratings agency Fitch said on Friday it saw no immediate impact on its ratings of Adani Group entities and their securities, following U.S. short-seller Hindenburg Research’s report last week.Hindenburg‘s scathing attack on the conglomerate questioned the firm’s debt levels and use of tax havens, but the Group has called the report baseless and affirmed its financials are strong. “Our ong...

The key highlights from HCLT’s analyst meet are the impact of macro on demand, drop in discretionary spending in hitech, telecom and a few other verticals, and furloughs has been higher than expected. The company now expects revenue growth for FY2023 estimates to be at the lower end of its guidance band. The bookings trend will likely be robust for the December 2022 quarter and reasonably healt...